These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26960887)

  • 41. Polypill as geri-tonic.
    Sherman FT
    Geriatrics; 2003 Aug; 58(8):7-8. PubMed ID: 12938247
    [No Abstract]   [Full Text] [Related]  

  • 42. What happened to the polypill?
    Watts G
    BMJ; 2008 Sep; 337():a1822. PubMed ID: 18819953
    [No Abstract]   [Full Text] [Related]  

  • 43. Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndrome.
    Deharo P; Quilici J; Bonnet G; Pankert M; Verdier V; Morange P; Alessi MC; Bonnet JL; Cuisset T
    Int J Cardiol; 2014 Mar; 172(1):e1-2. PubMed ID: 24438924
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pharmacologic prevention of cardiovascular diseases. Summary and perspectives].
    Kübler W
    Z Kardiol; 1992; 81 Suppl 4():221-2. PubMed ID: 1290302
    [No Abstract]   [Full Text] [Related]  

  • 45. [The polypill: optimal strategy for reduction of cardiovascular disease].
    Nathoe HM; Doevendans PA
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1740. PubMed ID: 16114290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term continuation on cardiovascular drug treatment in patients with coronary heart disease.
    Wald DS; Morton G; Walker K; Iosson N; Curzen NP
    Ann Pharmacother; 2007 Oct; 41(10):1644-7. PubMed ID: 17785612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin.
    Gesheff MG; Franzese CJ; Bliden KP; Contino CJ; Rafeedheen R; Tantry US; Gurbel PA
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):645-53. PubMed ID: 25098174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The polypill concept.
    Wald NJ; Wald DS
    Postgrad Med J; 2010 May; 86(1015):257-60. PubMed ID: 20448221
    [No Abstract]   [Full Text] [Related]  

  • 49. Time to implement the polypill approach.
    Holt S
    N Z Med J; 2009 Jun; 122(1296):88-9. PubMed ID: 19652688
    [No Abstract]   [Full Text] [Related]  

  • 50. Why is there more heat than light concerning the polypill?
    Rodgers A; Patel A
    BMJ; 2008 Oct; 337():a2162. PubMed ID: 18936069
    [No Abstract]   [Full Text] [Related]  

  • 51. Aspirin for the primary prevention of vascular events?
    Morgan G
    Public Health; 2009 Dec; 123(12):787-8. PubMed ID: 19914670
    [No Abstract]   [Full Text] [Related]  

  • 52. Polypill inventor puts product online after failing to get backing from industry.
    Kmietowicz Z
    BMJ; 2013 Jun; 346():f3991. PubMed ID: 23783364
    [No Abstract]   [Full Text] [Related]  

  • 53. Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature review.
    McKenney JM
    Postgrad Med; 2012 Jan; 124(1):7-20. PubMed ID: 22314110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-adherence to cardiovascular medications.
    Kolandaivelu K; Leiden BB; O'Gara PT; Bhatt DL
    Eur Heart J; 2014 Dec; 35(46):3267-76. PubMed ID: 25265973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A look at the polypill story 10 years later.
    Wilkinson E
    Eur Heart J; 2013 Jul; 34(27):2019-20. PubMed ID: 23853173
    [No Abstract]   [Full Text] [Related]  

  • 56. The polypill concept.
    Wald NJ; Wald DS
    Heart; 2010 Jan; 96(1):1-4. PubMed ID: 20019207
    [No Abstract]   [Full Text] [Related]  

  • 57. [Coronary disease: benefits of aspirin. What dose for which disease?].
    Michel PL
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):204-10. PubMed ID: 8024235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Polypill in the prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe.
    Thom S; Field J; Poulter N; Patel A; Prabhakaran D; Stanton A; Grobbee DE; Bots ML; Reddy KS; Cidambi R; Rodgers A
    Eur J Prev Cardiol; 2014 Feb; 21(2):252-61. PubMed ID: 23038750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Has the polypill finally proven its worth?
    Treadwell J
    Drug Ther Bull; 2019 Dec; 57(12):178. PubMed ID: 31776139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.